AllianceBernstein
NNVC icon

AllianceBernstein’s NanoViricides NNVC Stock Holding History

AllianceBernstein’s Portfolio NNVC Stock Details NNVC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-140
Closed -$6K – 3184
2015
Q1 		$6K Hold
140
– – ﹤0.01% 3402
2014
Q4 		$8K Hold
140
– – ﹤0.01% 3330
2014
Q3 		$8K Sell
140
-140
-50% -$11K ﹤0.01% 3312
2014
Q2 		$24K Buy
+280
New +$19.9K ﹤0.01% 3207

Other funds holding NNVC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CG
Colony Group Boston, Massachusetts $6.66B AUM 18.65% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

AllianceBernstein's NNVC Position: Q2 2015 in Review

AllianceBernstein sold out of NanoViricides (NNVC) in Q2 2015, closing a stake of 140 shares — an estimated $6K sold.

AllianceBernstein first reported a position in NNVC in Q2 2014 and held it in 4 quarters. The position peaked at $24K in Q2 2014. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2015.

  • AllianceBernstein reported no remaining NanoViricides position as of Q2 2015 after selling out during the quarter.
  • AllianceBernstein sold 140 NanoViricides shares in Q2 2015, an estimated $6K.
  • AllianceBernstein first reported a position in NanoViricides in Q2 2014 and held it in 4 quarters.
  • AllianceBernstein's NanoViricides position peaked at $24K in Q2 2014.
  • 48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2015.

Based on AllianceBernstein's 13F filing for Q2 2015, filed 14 Aug 2015.